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Abstract The yeast ATP-binding cassette transporter Pdr5p
mediates pleiotropic drug resistance (PDR) by e¥uxing a vari-
ety of xenobiotics. Immunoblotting demonstrates that Pdr5p
levels are high in the logarithmic growth phase, while its levels
decrease sharply when cells exit exponential growth. Here, we
show that PDR5 promoter activity is dramatically reduced when
cells stop growing due to a limitation of glucose or nitrogen or
when they approach stationary phase. Interestingly, Pdr3p, a
major transcriptional regulator of PDR5, shows the same reg-
ulatory pattern. Feeding glucose to starved cells rapidly re-in-
duces both PDR5 and PDR3 transcription. Importantly, dimin-
ished Pdr5p levels, as present after starvation, are rapidly
restored in response to xenobiotic challenges that activate the
transcription factors Pdr1p and Pdr3p. Our data indicate a role
for yeast Pdr5p in cellular detoxi¢cation during exponential
growth.
+ 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
In Saccharomyces cerevisiae, ATP-binding cassette (ABC)
transporters are involved in a phenomenon known as pleio-
tropic drug resistance (PDR), which is similar to multidrug
resistance observed in mammalian cells. One of the best-char-
acterized proteins involved in PDR is the yeast Pdr5p ABC
e¥ux pump, a polytopic plasma membrane protein consisting
of 12 predicted transmembrane-spanning K-helices and two
ATP-binding domains [1^4]. Like its functional homologues
Snq2p [5] and Yor1p [6], Pdr5p extrudes hundreds of struc-
turally and functionally unrelated xenobiotics across the plas-
ma membrane [5,7^10]. Despite Pdr5p being one of the best-
characterized ABC drug e¥ux pumps in yeast, its physiolog-
ical function is still unclear, although it is generally believed to
play a role in cellular detoxi¢cation processes.
Transcription of yeast ABC genes such as PDR5 [11,12],
SNQ2 [13], PDR10, PDR15 [14], YOR1 [6], is controlled by
the Zn(II)2Cys6 zinc ¢nger regulators Pdr1p [15], Pdr3p [16]
and Yrr1p [17]. The Pdr1p/Pdr3p transcription factors share
partially overlapping function and control their target pro-
moters by binding to the pleiotropic drug resistance elements
(PDREs). Both regulators can form homo- or heterodimers to
modulate target promoter activities [18].
PDR5 transcription control by Pdr1p and Pdr3p occurs
through four PDREs [14,19]. Recent ¢ndings indicate that
PDR5 can be induced by some of its drug substrates such
as 2,4-dichlorophenol (DCP), as well as by membrane deter-
gents [18,20]. Furthermore, a high expression of both Pdr5p
and Pdr3p is observed upon loss of the mitochondrial func-
tion or lack of functional F0-ATPase [21,22]. This Pdr5p in-
duction through as yet unknown signals requires both PDREs
in the PDR5 promoter and Pdr3p. Interestingly, PDR3 is also
controlled by two perfect PDREs in its promoter, which per-
haps involves an autoregulatory loop [23]. Di¡erent regula-
tory e¡ects of Pdr1p/Pdr3p, including both positive and neg-
ative control of individual targets, have been observed when
comparing the expression levels of PDR5, PDR10 and PDR15
in pdr1v or pdr3v strains [14]. Despite entertaining the same
PDREs, deletion of PDR1 reduces PDR5 expression, but in-
creases PDR15 mRNA levels [14]. Another zinc ¢nger tran-
scription factor, Rdr1p, has a negative role in controlling
PDR5 and PDR15 in a PDRE-dependent manner [24]. Hence,
Pdr1p/Pdr3p-dependent gene regulation varies considerably
between di¡erent promoters, probably due to other factors
present in the respective context [14].
In this study we analyzed the regulation of the PDR5 pro-
moter throughout the growth phase of yeast cells. Pdr5p levels
decrease rapidly when cells stop growth by exiting the expo-
nential growth phase, growth on non-fermentable carbon
sources or by limitation of nutrients such as glucose or nitro-
gen. This regulatory pattern was also observed for the dedi-
cated regulator Pdr3p, but not for Pdr15p, another Pdr1p/
Pdr3p target gene. Nevertheless, low levels of PDR5 expres-
sion on non-fermentable carbon sources still allow induction
by xenobiotic compounds activating Pdr1p/Pdr3p, indicating
that the PDREs are functional under these conditions. These
results suggest that Pdr5p functions as a cellular detoxi¢cation
determinant under logarithmic growth conditions.
2. Materials and methods
2.1. Yeast strains, plasmids and growth conditions
Rich medium (YPD) and synthetic medium (SC), supplemented
with appropriate auxotrophic components, were prepared as described
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elsewhere [25]. Glucose starvation was carried out in YPGE medium
containing 1% ethanol and 2% glycerol instead of glucose. For nitro-
gen starvation, cells were grown on SC medium and then shifted to
SC medium without amino acids and ammonium sulfate containing
only 10% of the usual concentrations of essential amino acids.
Yeast strains and plasmids used in this study are listed in Table 1.
Yeast strains YJH1 (pdr1v : :HIS3Mx6) and YYA18
(pdr3v : :KanMx6) were obtained by genomic integration of appropri-
ate polymerase chain reaction (PCR) products synthesized from the
plasmids pFA6aHIS3Mx6 and pFA6aKanMx6 [26]. For strain
YYA20, the integrating plasmid pCS5zi, carrying the lacZ gene under
the control of the PDR5 promoter, was linearized with NcoI and
integrated into the URA3 locus of YPH499 cells. Plasmid pRE104
was obtained by recombination of a PCR product containing GFP-
HIS3Mx6, which was ampli¢ed from pCKSF1 [27] containing GFP-
HIS3Mx6 fused to the C-terminus of PDR5. Correct genomic inte-
gration of all constructs was veri¢ed by PCR analysis.
2.2. Preparation of extracts and immunoblotting
For immunoblot analysis, 3 OD600 equivalents of cells were har-
vested, diluted in 1 ml water and incubated on ice with 150 Wl YEX
lysis bu¡er (1.85 M NaOH, 7.5% L-mercaptoethanol) for 10 min.
Proteins were precipitated by adding 150 Wl of 50% trichloroacetic
acid. Samples were centrifuged at 13 000Ug and the pellet was resus-
pended in sample bu¡er (40 mM Tris^HCl pH 6.8, 8 M urea, 5%
sodium dodecyl sulfate (SDS), 0.1 mM EDTA, 0.1 g/l bromophenol
blue, 1% L-mercaptoethanol). Proteins were separated through SDS^
polyacrylamide gel electrophoresis gels and blotted onto nitrocellulose
membranes. Pdr5p was immunodetected using polyclonal anti-Pdr5p
serum ‘Gaston 6’ [28]. HA-Pdr3p was detected with monoclonal anti-
HA antibody 16B12 (BabCo, Berkeley, CA, USA).
2.3. L-Galactosidase assays and £uorescence microscopy
L-Galactosidase measurements were carried out exactly as described
before [29]. All experiments were done at least in triplicate. Fluores-
cence studies were done in living cells grown in YPGE for 6 h, or
centrifuged and again transferred into YPD medium. Green £uores-
cent protein (GFP) was visualized using a Zeiss Axiovert microscope,
images were obtained using a Quantix CCD camera (Roper Scienti¢c)
with IP LAB software (Spectra Services) and processed in Photoshop
5.5 (Adobe).
2.4. Northern analysis
RNA preparation and separation was done exactly as described
[14]. The membrane was prehybridized in 10UDenhardt’s bu¡er (1
g Ficoll 400, 1 g polyvinylpyrrolidone, 1% (w/v) bovine serum albu-
min fraction V), 2USSC, 1% SDS for 3 h at 65‡C. Probes (PDR5 : 960
bp, GAP1 : the ¢rst 495 bp) were labeled using Megaprime labeling kit
and added to the prehybridization solution after puri¢cation of the
radiolabeled probe through a NICK column and subsequent heat
denaturation. After an overnight incubation at 65‡C, the membrane
was washed with 2USSC, 1% SDS and 1USSC, 1% SDS, both at
65‡C, and analyzed with a Phosphor Imager (Storm 1840, Molecular
Dynamics).
2.5. In vivo footprint analysis
Cells were grown in exponential growth phase in SC medium for
four generations and then shifted to YPD or YPGE for 2 h. Cells
Table 1
Yeast strains used in this study
Yeast strain Relevant genotype Source
YPH499 MATa ura3-52 leu2-v1 his3-v200 lys2-801a trp1-v1 ade2-v101oc [34]
YKKA7 pdr5v : :TRP1 ; otherwise isogenic to YPH499 [2]
YJH1 pdr1v : :HIS3Mx6 ; otherwise isogenic to YPH499 This study
YYA18 pdr3v : :KanMx6 ; otherwise isogenic to YPH499 This study
YYA20 ura3-52: :PDR5-lacZ-URA3 ; otherwise isogenic to YPH499 This study
YCS-15HA PDR15-3HA-KanMx6 ; otherwise isogenic to YPH499 This study
W303-1A MATa ura3-52 leu2-v1 his3-v200 lys2-801a trp1-v1 ade2-v101oc [13]
FY1679-28c MATa ura3-52 his3-v200 leu2-v1 trp1-v63 [18]
nav1 pdr1v : :TRP1 ; otherwise isogenic to FY1679-28c [16]
nav3 pdr3v : :HIS3 ; otherwise isogenic to FY1679-28c [16]
nav1v3 pdr1v : :TRP1 pdr3v : :HIS3 ; otherwise isogenic to FY1679-28c [16]
YRP11 HA-PDR3-LEU2 ; otherwise isogenic to FY1679-28c [18]
Fig. 1. Pdr5p levels decrease when cells exit exponential growth phase. YPH499 (A) and YCS-15HA (B) cells were inoculated in YPD medium
to an OD600 of 0.2 and then cultured for 5 days. Samples were initially taken every 90 min (OD600 0.5^3.7), then every 2 h (until OD600 9.0
(A) or 10 (B)), and then every 24 h. The OD600 was measured, protein extracts were prepared and Pdr5p and Pdr15-HA levels were detected
by immunoblotting using polyclonal anti-Pdr5p antibodies or the anti-HA antibodies 16B12, respectively. Cross-reactions against the anti-Pdr5p
(Pdr5p-CR) and the anti-HA antibodies (HA-CR) were used as loading controls to con¢rm equal sample loading.
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were harvested and in vivo footprints were carried out exactly as
previously described [18] using the primers (Pdr5-220as 5P-ACATCA-
CAATTATATATGTATAGGAGAGGCC-3P and Pdr5-530s 5P-
AGAAAACGTCCGTGGAGAACCATTCGGTCG-3P). Gels were
scanned using a Phosphor Imager (Storm 1840, Molecular Dynamics)
and quanti¢ed (Image Quant 5.0, Molecular Dynamics).
3. Results
3.1. Pdr5p levels decrease when cells enter stationary phase
Pdr5p is highly expressed in logarithmically growing cells.
We therefore investigated Pdr5p expression levels under di¡er-
ent growth conditions (Fig. 1). YPH499 (Fig. 1A) and YCS-
15HA (Fig. 1B) cells were grown in YPD for 5 days, samples
were taken ¢rst every 90 min and later once per day and
subjected to immunoblotting. From OD600 0.4 to 7.0, Pdr5p
appeared as a strong band on immunoblots (Fig. 1). However,
in cultures exceeding an OD600 of 7, which coincides with the
end of exponential growth, cellular Pdr5p levels decreased
sharply and rapidly. After the culture passed an OD600 of
9.0, Pdr5p levels remained very low albeit detectable. To
prove that this expression pattern is speci¢c to Pdr5p, we
tested the levels of another yeast ABC transporter, Pdr15p,
one of the closest homologues of Pdr5p. Interestingly, and in
contrast to Pdr5p, Pdr15p-HA levels increased strongly during
later growth stages (Wolfger et al., submitted for publication)
and remained constant over the 4 days following the post-
diauxic shift. Hence, these results demonstrate that Pdr5p is
strongly expressed during exponential growth but its levels
decrease rapidly at the end of logarithmic growth.
3.2. PDR5 levels are diminished in cells limited for growth or
nutrients
Upon exit of the exponential growth phase, yeast cells en-
counter various adverse conditions, including glucose, nitro-
gen or nutrient limitation, but also su¡er from accumulation
of catabolites, some of which are toxic and thus exert growth-
inhibitory e¡ects. To test whether some of these conditions
in£uence Pdr5p expression, we ¢rst starved cells for glucose.
Logarithmically growing YPH499 cells were shifted from
YPD to YPGE medium containing glycerol/ethanol as non-
fermentable carbon sources. Samples were taken from YPD-
grown cells and after 2 h of growth in YPGE. Then, YPGE
was either replaced by YPD, or 2% of glucose was added to
the YPGE culture. Northern blotting showed high PDR5
mRNA levels in YPD-grown cells (Fig. 2A). However, after
only 2 h in YPGE, PDR5 mRNA levels were nearly abol-
ished. Replacing the non-fermentable carbon sources by glu-
cose again restored PDR5 expression within 20 min. Addition
of 2% glucose to YPGE medium also increased PDR5 after 40
min, demonstrating that addition of glucose elicits a signal for
PDR5 induction.
To analyze whether this regulation is dependent on the
PDR5 promoter, YYA20 cells carrying a PDR5-lacZ reporter
gene were grown in YPD to an OD600 of 1.0 and shifted to
YPGE medium for 16 h. The YPGE medium was then re-
placed by YPD for 1 h. The high L-galactosidase activities in
the exponential growth phase were reduced to about 10%
after 16 h of glucose limitation (Fig. 2B). Addition of YPD
restored about 40% of the original L-galactosidase activity
within 1 h.
The induction of Pdr5p following glucose starvation was
also directly visualized by £uorescence microscopy using
YKKA7 cells expressing PDR5-GFP from plasmid pRE104
(Fig. 1C). The typical rim staining of Pdr5p was completely
absent after 12 h of glucose limitation. However, 20 min after
shifting from YPGE to YPD, a faint staining of the plasma
membrane appeared, which was more pronounced after 1 h
(Fig. 2C), indicating restored Pdr5p biogenesis and its proper
plasma membrane targeting.
To test whether a lack of glucose is the only signal trigger-
ing Pdr5p repression, we also performed nitrogen starvation
experiments (Fig. 3). YPH499 cells were grown to an OD600
of 1.0 and SC medium replaced by nitrogen starvation me-
dium. Northern blot analysis revealed that PDR5 mRNA lev-
els were severely diminished after 4 h of nitrogen starvation
and remained low during a 24 h period (Fig. 3A). Nitrogen
starvation was con¢rmed by the sharp increase of the GAP1
Fig. 2. Pdr5p is repressed during growth on non-fermentable carbon
sources. A: YPH499 cells were grown in YPD to an OD600 of 1.0
(YPD), supplied with YPGE for 2 h (YPGE), before replacing
YPGE by YPD (YPD, 20P, 40P, 60P) or glucose addition to YPGE
(YPGE, 20P, 40P, 60P). Samples were taken and PDR5 mRNA levels
were detected by Northern blotting. B: Strain YYA20 was grown in
YPD to an OD600 of 1.0, shifted to YPGE for 16 h (YPGE), before
replacing YPGE by YPD for another 1 h (YPD). Cell extracts were
prepared and L-galactosidase enzyme activities were assayed in trip-
licate. C: YKKA7 strain carrying plasmid pRE104 was grown over-
night in YPGE (YPGE). Cells were then placed in YPD (YPD 20P,
YPD 1 h) and inspected by microscopy in a Zeiss Axiovert micro-
scope using £uoresceine isothiocyanate ¢lters.
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mRNA for the general amino acid permease within the ¢rst 4
h. Gap1p is known to be strongly up-regulated during nitro-
gen starvation [30]. However, Pdr5p levels were rapidly re-
plenished when nitrogen sources became available again.
YPH499 cells were grown in SC medium, shifted to nitrogen
starvation medium and incubated for 24 h. Starvation was
terminated by addition of ammonium sulfate as well as amino
acids to levels present in normal SC medium (Fig. 3B). The
high Pdr5p levels present in SC medium were severely dimin-
ished after a 18 or 24 h period of nitrogen limitation. Addi-
tion of nitrogen sources to the starvation medium swiftly re-
stored normal Pdr5p levels within 2 h (Fig. 3B). This was also
con¢rmed by L-galactosidase measurements in YYA20 cells,
where growth under nitrogen limitation for 18 h reduced the
L-galactosidase activity to about 30% of normal. However,
within 2 h after refeeding cells with SC medium, 60% of the
normal activity was recovered (data not shown). This demon-
strates that not only glucose starvation, but also lack of nitro-
gen strongly reduces PDR5 promoter activity.
3.3. In£uence of Pdr1p and Pdr3p on expression of Pdr5p
under starvation conditions
PDR5 and several other yeast ABC e¥ux pumps are con-
trolled by the Pdr1p and Pdr3p regulators. The PDR3 pro-
moter also contains two perfect PDREs, and its regulation
proceeds through an autoregulatory loop. We thus tested
whether PDR3 is also repressed by glucose limitation. Strain
YRP11 expressing HA-Pdr3p under the control of its own
promoter was grown in YPD to an OD600 of 1.0, shifted to
YPGE for 6 h, and again transferred to YPD. As for Pdr5p,
HA-Pdr3p levels were strongly reduced upon onset of starva-
tion, but rapidly increased in the presence of glucose (Fig.
4A). Therefore, not only Pdr5p, but also one of its main tran-
scriptional regulators is repressed during growth on non-fer-
mentable carbon sources.
Next, we investigated the role of Pdr1p/Pdr3p in regulation
of Pdr5p under starvation conditions. YPH499, YJH1 (pdr1v)
and YYA18 (pdr3v) cells growing exponentially in YPD me-
dium were put on YPGE for 4 h and shifted back to YPD
(Fig. 4B). In Northern blot analysis, all three strains showed
Fig. 3. Nitrogen starvation strongly decreases PDR5 expression. A:
YPH499 cells were grown in SC medium to an OD600 of 1.0 (0).
Nitrogen depletion was carried out in N-starvation medium for 24
h. Samples were taken and PDR5 and GAP1 mRNA levels were de-
tected by Northern blotting. B: YPH499 cells were grown in SC
medium to an OD600 of 1.0 (0), depleted for nitrogen over 24 h, be-
fore addition of ammonium sulfate as well as amino acids to termi-
nate nitrogen starvation. Samples were taken at the indicated time
points and Pdr5p and Pdr12p levels were detected by immunoblot-
ting as described above.
Fig. 4. In£uence of Pdr1p and Pdr3p on PDR5 repression. A:
YRP11 cells were grown in YPD to an OD600 of 1.0 (YPD), shifted
to YPGE for 6 h (2, 4, 6 h) and back-transferred into YPD for 90
min (0.5, 1, 1.5 h). Samples were taken and HA-Pdr3p levels were
detected by immunoblotting using monoclonal anti-HA antiserum
16B12. Cross-reactions against the anti-HA antibodies (HA-CR)
were used as loading controls to con¢rm equal sample loading. B:
Strains YPH499, YJH1 (pdr1v) and YYA18 (pdr3v) were grown in
YPD to an OD600 of 1.0 (YPD), YPGE was added for 2 h (YPGE)
and again replaced by YPD. PDR5 mRNA was detected by North-
ern blotting. C: FY1679-28c (a,c) and nav1v3 cells (b) were grown
in SC medium for 4 h and shifted to YPD (a,b) or to YPGE (c) for
2 h each. Cells were harvested and treated with DMS. DNA was
prepared and the methylation status of the perfect PDRE1 and
PDRE2 was detected by primer extension analysis. D: Topology
and position relative to the initiating methionine of all PDRE cis-
acting motifs in the PDR5 promoter. White boxes, perfect PDRE;
gray boxes, degenerate PDRE; bold letters in the sequence of the
PDRE1 and PDRE2 consensus motifs indicate protected nucleotide
bases.
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almost identical changes in PDR5 mRNA levels at all time
points. Reduced levels of PDR5 mRNA were evident after 1
and 2 h of starvation, while PDR5 was rapidly re-induced
within 15^30 min after the shift to YPD medium (Fig. 4B).
Therefore, neither Pdr1p nor Pdr3p alone can be responsible
for the repression of PDR5.
To test whether Pdr1p and Pdr3p decorate the PDR5 pro-
moter during glucose starvation, we performed in vivo foot-
print experiments of FY1679-28c wild type cells and cells
lacking both regulators. Cells were grown in SC medium to
the exponential growth phase for 4 h. One aliquot of each
culture was shifted to YPGE, while another was grown in
YPD. After 2 h, cells were harvested, treated with DMS,
and the methylation status of the PDRE1 and PDRE2 cis-
acting sites was analyzed by primer extension (Fig. 4C). As
shown previously, primer extension analysis detects modi¢ed
nucleotide bases, thus revealing a direct promoter binding of
Pdr1p or Pdr3p to its cognate PDRE motifs [18]. In wild type
cells, methylation of PDRE1 and PDRE2 in the PDR5 pro-
moter was clearly reduced when compared to the deletion
strain (Fig. 4C, a+b), indicating binding of both transcription
factors. In the control strain lacking both Pdr1p and Pdr3p,
the methylation of PDREs was not reduced. However, we did
not detect a di¡erence in the methylation protection in wild
type cells harvested from YPD or YPGE, (Fig. 4C, a+c),
suggesting that various PDRE motifs attract Pdr1p, Pdr3p
and/or Pdr1p/Pdr3p binding even in the absence of glucose,
as already shown earlier for logarithmically growing cells [18].
3.4. Repressed Pdr5p can be induced by drug treatment in
stationary cells
Recently, Pdr5p was shown to be induced by some of its
drug substrates, including the herbicide DCP [20] (Mamnun et
al., in preparation). To test the re-induction of Pdr5p by DCP
under starvation conditions, W303-1A cells were grown to an
OD600 of about 10.0. Samples were taken when cells were in
exponential growth phase, as well as prior to DCP stress
treatments. Then, 0.3 mM DCP (Fig. 5C) or 100 WM poly-
oxyethylene-9-laurylether (POELE) (Fig. 5D) was added to
the cultures, while one control aliquot remained untreated
(Fig. 5A). Another culture aliquot was re-grown in YPD to
the exponential growth phase, before imposing DCP stress
(Fig. 5B). Samples were taken after 1, 2 and 3 h and Pdr5p
levels were detected by immunoblotting. As observed before,
DCP did not further increase the already high Pdr5p levels in
exponentially growing cells. However, cells at an OD600 of 10,
which had severely reduced Pdr5p levels, showed a massive
increase of expression in response to DCP treatment. POELE
also increased Pdr5p expression, albeit to a much lower level.
Untreated control cells (Fig. 5A) showed that Pdr5p levels
remained low in the absence of these stresses. Notably, other
known Pdr5p substrates such as ketoconazole failed to restore
levels of Pdr5p expression (data not shown). Taken together,
these data suggest a role for Pdr5p in cellular detoxi¢cation
during logarithmic growth of cells or when cells can rely upon
optimal growth conditions.
4. Discussion
Although the physiological role of the Pdr5p e¥ux pump is
not fully understood, it is generally believed that Pdr5p might
play a role in cellular detoxi¢cation. Pdr5p, which is highly
abundant in exponentially growing cells, e¥uxes hundreds of
cytotoxic compounds [1^4,7^9], many of which may actually
resemble toxic metabolites. During periods of their life cycle,
yeast cells also have to cope with limiting or suboptimal
growth conditions. Therefore, we analyzed whether PDR5 ex-
pression is modulated by suboptimal conditions such as non-
fermentable carbon sources or nutrient starvation. Interest-
ingly, Pdr5p levels are indeed dramatically reduced when cells
encounter these growth-limiting conditions because of a re-
duced transcription or repression of the PDR5 gene.
The transcription factors Pdr1p/Pdr3p are considered the
main regulators of Pdr5p expression. Indeed, these master
regulators are responsible for high levels of PDR5 transcrip-
Fig. 5. Pdr5p is induced by its substrates in stationary phase.
W303-1A cells were inoculated into YPD to an OD600 of 0.2 and
grown for 24 h, or until reaching an OD600 of 10. Culture aliquots
were left untreated (A) or stressed with 0.3 mM DCP (C) or 100
WM POELE (D) for the indicated time periods. Another YPD cul-
ture aliquot was grown for 24 h without drugs; next, cells were re-
inoculated into fresh YPD, grown to the exponential phase for 4 h,
followed by treatment with 0.3 mM DCP (DCP-short) for various
times as indicated (B). The panels refer to the untreated control
(A), DCP-short for logarithmic cells (B), DCP treatment of station-
ary phase cells (C), and POELE treatment (D). Samples were taken
and cell free extracts subjected to immunoblotting for Pdr5p levels
(A^D). Immunoblotting for War1p levels served as loading control
to con¢rm equal sample loading.
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tion in exponentially growing cells PDR15 [6,14]. Interest-
ingly, a close inspection of published microarray datasets
[31] (see also http://www-genome.stanford.edu/yeast_stress)
for expression levels of other Pdr1p/Pdr3p target genes during
stationary phase, diauxic shift and nitrogen depletion showed
that only PDR5, but not SNQ2, YOR1, PDR10 or PDR15 are
strongly repressed under these conditions. By contrast, expres-
sion of other ABC genes such as YOR1, PDR15 and PDR10
is induced during prolonged stationary phase [31], suggesting
that PDR5 repression does not merely re£ect a general re-
sponse of Pdr1p/Pdr3p targets. However, our data also
show that at least one PDRE-regulated gene, PDR3, is co-
regulated with Pdr5p under glucose limitation conditions. A
similar phenomenon was found in cells with impaired mito-
chondrial activities [21]. In b0 cells, transcription of PDR5,
PDR15 and PDR3 is increased [21,22,32], while SNQ2 and
YOR1 were only mildly a¡ected [22]. Hence, regulation of
Pdr1p and Pdr3p is distinct and speci¢c for every target
gene, implying that additional regulatory mechanisms must
exist [33], perhaps depending on the actual growth conditions
or the cellular energy status. One possibility of speci¢c control
of Pdr1p and Pdr3p targets is the formation of various Pdr1p/
Pdr3p homo- and/or heterodimers [18] depending on the pro-
moter context. However, this appears unlikely at least for
Pdr5p from these data, since single deletions of Pdr1p or
Pdr3p do not in£uence PDR5 repression during glucose star-
vation. In vivo footprint analysis demonstrates that binding of
Pdr1p and Pdr3p to at least two PDR5 promoter PDREs is
not inhibited by glucose limitation, indicating constitutive oc-
cupancy of the PDR5 promoter by Pdr1p/Pdr3p. Neverthe-
less, since Pdr1p and Pdr3p are the main regulators of PDR5
expression, they are likely to have a pivotal role in the growth
stage-speci¢c regulation described here. Our results therefore
imply that Pdr1p and Pdr3p might recruit additional and as
yet unidenti¢ed transcription factors that lead either to PDR5
activation under optimal growth conditions or to repression
when cells have to cope with growth-limiting conditions.
The identity of the regulators acting upstream of Pdr1p and
Pdr3p remains an open question. We excluded several candi-
date transcription factors or glucose sensors (data not shown).
The zinc ¢nger regulator Rdr1p was identi¢ed as a repressor
of PDR5, which displays its inhibitory e¡ects via the PDREs
[24]. However, deletion of RDR1 increased Pdr5p levels dur-
ing exponential growth, which is consistent with its purported
negative e¡ect on Pdr5p expression regulation. Lack of
Rdr1p, however, does not prevent repression during nitrogen
starvation (data not shown). Other known regulators required
for the transition from fermentative to respiratory growth,
like the SNF1 kinase or protein kinase A, are also not re-
quired for the transcriptional regulation of PDR5 under these
conditions (data not shown). Therefore, the signals as well as
the pathways that regulate PDR5 repression under growth-
limiting conditions are unclear at the moment.
The tight regulation of Pdr5p levels may be interpreted in
several ways. High expression during exponential growth
might point to a role in detoxi¢cation in this growth stage.
Further, Pdr5p levels might serve as a precaution to ¢ght
xenobiotic attacks, as they mount due to competition with
other competitor organisms when nutrients are not limiting.
By contrast, high expression levels of Pdr5p might be detri-
mental under conditions when energy supplies or nutrients
become limiting. Alternatively, Pdr5p could directly interfere
with membrane features such as selective permeability for
molecules that are required to re-enter growth from stationary
phase. Removal of Pdr5p in non-growing cells would prevent
pumping and loss of such molecules, and may thus lead to
reduced ability to resume growth. In this respect it is interest-
ing to note that Pdr5p can be re-induced even in starved cells
by some of its drug substrates, including DCP or the detergent
POELE. DCP is a highly toxic bacterial degradation product
of the plant herbicide 2,4-dichlorophenoxy acetic acid (2,4-D).
Indeed, Pdr5p is induced by 2,4-D and it has been implicated
in the extrusion of 2,4-D [20]. However, this induction was
only observed at the mRNA level, and Pdr5p protein levels
were only slightly elevated (Mamnun et al., in preparation),
which might be explained by the high levels of basal Pdr5p
expression in exponentially growing cells. Nevertheless, these
data are consistent with results from our work, which allow
for the conclusion that Pdr5p is a stress-responsive gene
present mainly during phases of rapid growth where constant
detoxi¢cation is needed. The rapid re-induction of Pdr5p in
quiescent cells challenged by speci¢c stress signals suggests
that Pdr5p serves as a major detoxi¢cation safeguard for yeast
cells.
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